Acute Coronary Syndromes
From the Journals
Machine-learning model improves MI diagnosis
“It really is a game changer in terms of its potential to improve health efficiency,”
From the Journals
Age-specific cut-offs needed for cardiac troponin tests?
“If age-specific thresholds were deployed, then our data suggest that thresholds used to diagnose myocardial injury would need to be higher in...
Conference Coverage
Cardiovascular disease deaths rise on and after high-pollution days
High levels of air pollution were linked to higher risk of death from MI and stroke in a Polish population.
From the Journals
Antiphospholipid antibodies linked to future CV events
The study raises the possibility of one day treating the immune system in some individuals for the prevention and treatment of cardiovascular...
From the Journals
Some diets better than others for heart protection
From the Journals
Subclinical CAD by CT predicts MI risk, with or without stenoses
Even without symptoms, more atherosclerosis by CT angiography means greater MI risk, which climbs even further if there are obstructive lesions....
From the Journals
Commotio cordis underrecognized, undertreated outside of sports
Mortality is higher and resuscitation rates are lower when this underappreciated cause of sudden cardiac arrest occurs, especially among young...
From the Journals
One or two high-step days may reduce mortality risks
Adults who took roughly 4 miles of steps 1 or 2 days a week showed longevity benefits similar to those of adults with more days of similar step...
Latest News
Even small changes in fitness tied to lower mortality risk
Small changes in cardiorespiratory fitness may have a big impact on health and mortality risk.
From the Journals
Sports-related sudden cardiac arrest ‘extremely’ rare in women
Women have a significantly lower risk of suffering cardiac arrest during sports, which begs the question of risk-adapted screening in women,...
News
FDA expands evinacumab approval to younger kids with HoFH
The agency has okayed evinacumab-dgnb for patients aged 5-11 with homozygous familial hypercholesterolemia.